Discover more

Overcome the challenges of modern drug discovery

We partner with our clients to provide an end-to-end solution and comprehensive research services.

  • Identification and validation of potential targets and biomarkers for disease intervention.
  • Early detection and patient selection, which accelerates discovery.
  • Development of modality-specific therapeutics for targeted disease focus
  • Proven experience in neo-antigen discovery.

We have deep experience of the requirements for successful end-to-end delivery, we also have unique insight that allows us to optimise study design and identify the data quality required for each individual step of your research.

Who are we

Operational team